Researcher at Tabriz University of Medical Sciences Has Published New Study Findings on Breast Cancer (Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer).

A recent study conducted at Tabriz University of Medical Sciences explored the differences in the expression and promoter methylation of mitogen-activated protein kinase 1 (MAPK1) between tumor and marginal cells of breast cancer lesions. The study found a positive correlation between tumor stage and MAPK1 expression, as well as a significant association between MAPK1 expression and lymph node metastasis. However, there was no statistically significant difference in MAPK1 promoter methylation between tumor and marginal cells. The study suggests that MAPK1 expression may be a promising biomarker for evaluating oncogenic activity in breast cancer patients, but MAPK1 promoter methylation is not a suitable biomarker. [Extracted from the article]

Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)